EQS-News: Hello SDAX! SCHOTT Pharma reaches next milestone as a publicly listed company
EQS-News: SCHOTT Pharma AG & Co. KGaA
- EQS-News: SCHOTT Pharma AG & Co. KGaA
The issuer is solely responsible for the content of this announcement. - Andreas Reisse, CEO of SCHOTT Pharma, said: “Following our successful IPO just a little over two months ago, SCHOTT Pharma’s inclusion in the SDAX shows that investors have confidence in our business model and see the potential of our company.
- The main criterion for the weighting of SDAX shares is market capitalization based on free float (minimum of 10%), which is around 23% for SCHOTT Pharma.
- The company went public on September 28 this year on the Frankfurt Stock Exchange, marking the largest German IPO of 2023.